Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study

被引：0
|
作者：
Ortega, Hector
Liu, Mark
Pavord, Ian
Brusselle, Guy
FitzGerald, J. Mark
Chetta, Alfredo
Katz, Lynn
Keene, Oliver
Yancey, Steven
Chanez, Pascal
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Exacerbation; Asthma; -; management; Inflammation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2906
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma
    Russell, Richard
    Brightling, Christopher
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 607 - 617
  • [2] Phenotyping Mepolizumab EXacerbations in severe eosinophilic asthma (MEX)
    McDowell, Pamela Jane
    Diver, Sarah
    Yang, Jieqiong Freda
    Borg, Catherine
    Busby, John
    Brown, Vanessa
    Shrimanker, Rahul
    Cox, Ciara
    Brightling, Christopher
    Chaudhuri, Rekha
    Pavord, Ian
    Heaney, Liam
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype
    Basu, Anirban
    Dalal, Anand
    Canonica, Giorgio Walter
    Forshag, Mark
    Yancey, Steven W.
    Nagar, Saurabh
    Bell, Christopher F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (02) : 121 - 131
  • [4] Characterisation of Exacerbations of Severe Eosinophilic Asthma on Mepolizumab Compared to Placebo
    Shrimanker, R.
    Keene, O.
    Bratton, D. J.
    Yancey, S.
    Heaney, L.
    Pavord, I. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] CHARACTERISATION OF EXACERBATIONS OF SEVERE EOSINOPHILIC ASTHMA ON MEPOLIZUMAB COMPARED TO PLACEBO
    Shrimanker, R.
    Keene, O.
    Bratton, D. J.
    Yancey, S. W.
    Heaney, L. G.
    Pavord, I. D.
    THORAX, 2019, 74 : A35 - A35
  • [6] Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
    Haldar, Pranabashis
    Brightling, Christopher E.
    Hargadon, Beverley
    Gupta, Sumit
    Monteiro, William
    Sousa, Ana
    Marshall, Richard P.
    Bradding, Peter
    Green, Ruth H.
    Wardlaw, Andrew J.
    Pavord, Ian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10): : 973 - 984
  • [7] MEPOLIZUMAB REDUCES EXACERBATIONS IN SEVERE EOSINOPHILIC ASTHMA: A REAL-WORLD STUDY.
    Harvey, E.
    Langton, D.
    Farah, C.
    Gillman, A.
    Harrington, J.
    Hew, M.
    Katelaris, C.
    Kritikos, V
    Radhakrishna, N.
    Stevens, S.
    Gibson, P.
    RESPIROLOGY, 2020, 25 : 105 - 105
  • [8] Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
    Shrimanker, Rahul
    Hargaden, Beverley
    Bradding, Peter
    Wardlaw, A. J.
    Brightling, C. E.
    Green, Ruth
    Bafadhel, Mona
    Pavord, I. D.
    Haldar, Pranab
    Heaney, L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [9] Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
    Howell, Imran
    Bratton, Daniel J.
    Hynes, Gareth
    Yancey, Steven W.
    Heaney, Liam G.
    Pavord, Ian D.
    Shrimanker, Rahul
    ERJ OPEN RESEARCH, 2024, 10 (04)
  • [10] Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
    Kim, Mi-Kyeong
    Park, Hae-Sim
    Park, Choon-Sik
    Min, Soung-Jun
    Albers, Frank C.
    Yancey, Steven W.
    Mayer, Bhabita
    Kwon, Namhee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 362 - +
12345